Market revenue in 2023 | USD 662.2 million |
Market revenue in 2030 | USD 1,326.3 million |
Growth rate | 10.4% (CAGR from 2023 to 2030) |
Largest segment | Sequencing by synthesis |
Fastest growing segment | Sequencing by synthesis |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Sequencing by synthesis, Sequencing by ligation, Sanger sequencing |
Key market players worldwide | Microbiome Insights Inc., BaseClear, Clinical Microbiomics, Mérieux NutriSciences Corporation, Mr Dna, Metabiomics, Rancho BioSciences, Second Genome, Zymo Research, uBiome |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to microbiome sequencing services market will help companies and investors design strategic landscapes.
Sequencing by synthesis was the largest segment with a revenue share of 57.01% in 2023. Horizon Databook has segmented the U.S. microbiome sequencing services market based on sequencing by synthesis, sequencing by ligation, sanger sequencing covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. market accounted for the major revenue share of microbiome sequencing services market. The local presence of several pharmaceutical & biotechnological entities & research institutions in the country and increase in the number of R&D programs related to cancer, infectious disorders, & precision medicine are responsible for the large share of the regional market.
These entities in turn are committed to addressing the unmet medical needs of patients in the U.S. as well as around the world through their studies. Furthermore, the U.S. market is majorly influenced by an increase in the prevalence of cancer and autoimmune disorders including GI disorders, which is boosting the demand for diagnostics for early cancer detection.
Over the past few decades, transcriptome profiling has emerged as a promising approach in the field of oncology, providing predictive and prognostic utility for cancer management. With the development of innovative, novel technologies such as NGS, the field of cancer management is witnessing a revolution.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. microbiome sequencing services market , including forecasts for subscribers. This country databook contains high-level insights into U.S. microbiome sequencing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account